Patient information leaflet from The Menopause Partnership (GP-led specialist care for women).
Understanding migraines and menopause
Migraine is a neurological condition that commonly affects women. Hormonal fluctuations, particularly changes in oestrogen levels, can influence migraine patterns.
During perimenopause and menopause, changing hormone levels may cause migraines to become more frequent, more severe, or less predictable. For some women, migraines improve after menopause; for others, they may worsen during the transitional years.
Why do migraines change in menopause?
Oestrogen plays an important role in stabilising the nervous system. When oestrogen levels fluctuate, particularly during perimenopause, this can trigger migraine attacks.
Perimenopause is often associated with:
- Irregular hormone fluctuations
- Shorter or longer cycles
- Unpredictable oestrogen drops
These hormonal shifts are a common trigger for migraine. After menopause, when hormone levels stabilise at a lower level, some women experience improvement in migraine frequency.
What symptoms may occur?
Migraine symptoms can include:
- Moderate to severe headache, often one-sided
- Throbbing or pulsating pain
- Sensitivity to light or sound
- Nausea or vomiting
- Visual disturbances (aura), in some women
Some women notice that migraines cluster around their menstrual cycle during perimenopause, while others experience more random attacks.
How can menopause affect different types of migraine?
Women with migraine without aura may notice worsening during perimenopause due to hormonal instability.
Women with migraine with aura require careful assessment before starting hormone therapy, as certain forms of oestrogen may increase stroke risk in this group. Specialist advice is important to ensure safe prescribing.
Treatment options
Management involves addressing both migraine control and hormonal stability.
Options may include:
- Standard migraine treatments (acute and preventative medications)
- Lifestyle measures such as regular sleep, hydration and stress management
- Hormone Replacement Therapy (HRT), where appropriate
Transdermal oestrogen (patch or gel) is generally preferred in women with migraine, as it provides more stable hormone levels and may reduce hormonal fluctuations.
HRT is not a treatment for migraine itself, but stabilising hormones may improve symptoms in some women. Treatment should always be individualised based on migraine type, cardiovascular risk and overall health.
Lifestyle considerations
Several factors can influence migraine frequency during perimenopause and menopause. Sleep disturbance, stress and anxiety, dehydration, skipped meals and alcohol intake are common triggers that may increase the likelihood of an attack. Maintaining regular daily routines, eating consistently, staying well hydrated and identifying individual triggers can help reduce migraine frequency.
When to seek medical advice
You should seek medical advice if migraines become more frequent or severe, if you develop new neurological symptoms, or if your migraine pattern changes significantly. Urgent medical assessment is required for sudden severe headache, new weakness, speech difficulty, or visual disturbance that differs from previous aura symptoms. A clinical review is also important before starting HRT if you have a history of migraine with aura.
Summary
Migraines can change during perimenopause and menopause due to fluctuating hormone levels. While some women experience worsening symptoms during this transition, others improve once hormone levels stabilise.
With appropriate assessment and tailored treatment – including careful consideration of HRT – migraines can often be effectively managed. Our menopause specialists can provide individualised guidance to support both hormonal and neurological health.
